These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 32430443)

  • 1. Physician Care Coordination and the Use of Psychotropic Polypharmacy in the Management of Pediatric Mental Disorders.
    Medhekar R; Fujimoto K; Aparasu RR; Bhatara VS; Johnson ML; Alonzo JP; Schwarzwald HL; Chen H
    J Manag Care Spec Pharm; 2019 Jan; 25(1):29-38. PubMed ID: 30589632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychotropic medication use and polypharmacy in children with autism spectrum disorders.
    Spencer D; Marshall J; Post B; Kulakodlu M; Newschaffer C; Dennen T; Azocar F; Jain A
    Pediatrics; 2013 Nov; 132(5):833-40. PubMed ID: 24144704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Psychotropic Medication Polypharmacy and an Objective Measure of Balance Impairment Among Middle-Aged Adults: Results from the US National Health and Nutrition Examination Survey.
    Bareis N; Sando TA; Mezuk B; Cohen SA
    CNS Drugs; 2018 Sep; 32(9):863-871. PubMed ID: 30014315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Longitudinal Analysis of Concerning Psychotropic Medication Regimens Among Adolescents in Foster Care.
    Palmer L; Herd T; Swanson AS; Felt J; Font S
    J Adolesc Health; 2023 Sep; 73(3):452-460. PubMed ID: 37318407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychotropic Medication Use and Polypharmacy Among Children and Adolescents Initiating Intensive Behavioral Therapy for Severe Challenging Behavior.
    O'Brien MJ; Pauls AM; Cates AM; Larson PD; Zorn AN
    J Pediatr; 2024 Aug; 271():114056. PubMed ID: 38615943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Utah psychotropic oversight program: collaboratively addressing antipsychotic use within youth in foster care without prior authorization.
    Monson ET; Shastri S; Chen D; Madden SL; Keeshin BR
    Front Psychiatry; 2023; 14():1271165. PubMed ID: 38025462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective cohort study of prescription drug use among youth with intellectual/developmental disabilities in British Columbia.
    Marquis S; Marquis NE; Lunsky Y; McGrail KM; Baumbusch J
    J Intellect Disabil Res; 2024 May; ():. PubMed ID: 38773818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychotropic medicines' prevalence, patterns and effects on cognitive and physical function in older adults with intellectual disability in Ireland: longitudinal cohort study, 2009-2020.
    Odalović M; Gorman A; Paul A; McCallion P; Burke É; MacLachlan M; McCarron M; Henman MC; Moran M; O'Connell J; Walsh M; Shankar R; Ryan C; O'Dwyer M
    BJPsych Open; 2024 Feb; 10(2):e39. PubMed ID: 38297892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of pneumonia admission with polypharmacy and drug use in community-dwelling older people.
    Hamaya H; Kojima T; Hattori Y; Akishita M
    Geriatr Gerontol Int; 2024 Apr; 24(4):404-409. PubMed ID: 38497333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interrupting the Cycle: Association of Parental Stress and Child/Youth Psychotropic Medication Nonadherence.
    Theall L; Ninan A; Arbeau K; Mannone J; Stewart SL
    Child Psychiatry Hum Dev; 2024 Aug; 55(4):909-915. PubMed ID: 36306028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric psychotropic polypharmacy.
    Zonfrillo MR; Penn JV; Leonard HL
    Psychiatry (Edgmont); 2005 Aug; 2(8):14-9. PubMed ID: 21152168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of parental job loss on psychotropic drug use in children: Long-term effects, timing, and cumulative exposure.
    Högberg B; Baranowska-Rataj A
    Adv Life Course Res; 2024 Jun; 60():100607. PubMed ID: 38569249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial: Psychotropic overprescribing to youth: scope of the problem, causes, and possible solutions.
    McLaren JL; Zito JM; Fegert JM; Barnett ER
    Front Psychiatry; 2024; 15():1418600. PubMed ID: 38774431
    [No Abstract]   [Full Text] [Related]  

  • 14. Psychotropic Medication and Psychotropic Polypharmacy Among Children and Adolescents in the US Child Welfare System.
    Radel LF; Ali MM; West K; Lieff SA
    JAMA Pediatr; 2023 Oct; 177(10):1107-1110. PubMed ID: 37603358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Subjective Experience of Youth Psychotropic Treatment.
    Floersch J
    Soc Work Ment Health; 2004 Mar; 1(4):51-69. PubMed ID: 20352031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of policy interventions on psychotropic polypharmacy in Japanese older adults.
    Takeshima M; Yoshizawa K; Ogasawara M; Kudo M; Itoh Y; Ayabe N; Mishima K
    Psychogeriatrics; 2024 Jul; ():. PubMed ID: 39010736
    [No Abstract]   [Full Text] [Related]  

  • 17. Psychotropic Polypharmacy Among Children and Youth with Autism: A Systematic Review.
    Ritter C; Hewitt K; McMorris CA
    J Child Adolesc Psychopharmacol; 2021 May; 31(4):244-258. PubMed ID: 33970024
    [No Abstract]   [Full Text] [Related]  

  • 18. High-level psychotropic polypharmacy: a retrospective comparison of children in foster care to their peers on Medicaid.
    Davis DW; Lohr WD; Feygin Y; Creel L; Jawad K; Jones VF; Williams PG; Le J; Trace M; Pasquenza N
    BMC Psychiatry; 2021 Jun; 21(1):303. PubMed ID: 34112146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Family Adverse Experiences and Psychotropic Polypharmacy Among US Youth: 2009-2015.
    dosReis S; Zhang C; Qato DM; Camelo Castillo W; Reeves G
    Pediatrics; 2020 Jun; 145(6):. PubMed ID: 32430443
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.